pentoxifylline has been researched along with Sclerosis, Systemic in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vascular problems are very common in systemic sclerosis with 95% of patients suffering with Raynaud's phenomenon at some stage in their illness." | 5.28 | Treatment of peripheral gangrene due to systemic sclerosis with intravenous pentoxifylline. ( Goodfield, MJ; Rowell, NR, 1989) |
| "Vascular problems are very common in systemic sclerosis with 95% of patients suffering with Raynaud's phenomenon at some stage in their illness." | 1.28 | Treatment of peripheral gangrene due to systemic sclerosis with intravenous pentoxifylline. ( Goodfield, MJ; Rowell, NR, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Souza, RB | 1 |
| Macedo, AR | 1 |
| Kuruma, KA | 1 |
| Macedo, PA | 1 |
| Borges, CT | 1 |
| Szabolcsi, O | 1 |
| Nagy-Toldi, A | 1 |
| Zeher, M | 1 |
| Végh, J | 1 |
| Garai, I | 1 |
| Csiki, Z | 1 |
| Szücs, G | 1 |
| Varga, J | 1 |
| Galuska, L | 1 |
| Sowemimo-Coker, SO | 1 |
| Kovacs, IB | 1 |
| Turner, P | 1 |
| Kirby, JD | 1 |
| Goldman, MP | 1 |
| Neĭko, IeM | 1 |
| Iatsyshyn, RI | 1 |
| Haustein, UF | 1 |
| Berman, B | 1 |
| Duncan, MR | 1 |
| Goodfield, MJ | 1 |
| Rowell, NR | 1 |
1 review available for pentoxifylline and Sclerosis, Systemic
| Article | Year |
|---|---|
[Current status and trends in treatment of scleroderma].
Topics: Captopril; Combined Modality Therapy; Dextrans; Epoprostenol; Humans; Immunosuppressive Agents; Nife | 1992 |
2 trials available for pentoxifylline and Sclerosis, Systemic
| Article | Year |
|---|---|
Pentoxyphylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis.
Topics: Adult; Antioxidants; Drug Therapy, Combination; Female; Fibrosis; Humans; Male; Middle Aged; Pentoxi | 2009 |
[Use of pentoxifylline in the treatment of systemic scleroderma].
Topics: Adult; Female; Hematologic Agents; Humans; Male; Microcirculation; Middle Aged; Pentoxifylline; Rayn | 2002 |
6 other studies available for pentoxifylline and Sclerosis, Systemic
| Article | Year |
|---|---|
[Systemic sclerosis in a patient suffering from breast cancer].
Topics: Adult; Amlodipine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Duct | 2012 |
Visualizing the effect of pentoxyphyllin infusion therapy on the circulation of the hand by Tc-99m DPTA scintigraphy.
Topics: Adult; Fingers; Hand; Humans; Middle Aged; Pentoxifylline; Radionuclide Imaging; Radiopharmaceutical | 2003 |
An improved filtration rate for measuring red cell deformability.
Topics: Dipyridamole; Erythrocytes; Hematocrit; Humans; Pentoxifylline; Raynaud Disease; Scleroderma, System | 1984 |
The use of pentoxifylline in the treatment of systemic sclerosis and lipodermatosclerosis: a unifying hypothesis?
Topics: Humans; Pentoxifylline; Scleroderma, Localized; Scleroderma, Systemic | 1994 |
Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin.
Topics: Cell Division; Collagen; Depression, Chemical; Fibroblasts; Fibronectins; Glycosaminoglycans; Humans | 1990 |
Treatment of peripheral gangrene due to systemic sclerosis with intravenous pentoxifylline.
Topics: Adult; Aged; Female; Fingers; Gangrene; Humans; Infusions, Intravenous; Male; Pentoxifylline; Sclero | 1989 |